Role of HLA in hematopoietic SCT

Bone Marrow Transplantation

Volumn 42, Issue SUPPL. 2, 2008, Pages

  Nowak, J ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

DONOR SELECTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC COMPATIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAFT HYBRIDIZATION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; HLA MATCHING; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INNATE IMMUNITY; OLIGONUCLEOTIDE PROBE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; ALLELES; DONOR SELECTION; GRAFT REJECTION; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVING DONORS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 55749108738     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.288     Document Type: Review

References (34)

1. Mullally A, Ritz J. Beyond HLA: The significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355-1362.
2. http://bioinformatics.nmdp.org/HLA/Allele_Codes/DNA_Type_Lookup/ dnatyp.pl?dna=.
3. Cano P, Klitz W, Mack SJ, Maiers M, Marsh SGE, Noreen H et al. Common and well-documented HLA alleles. Report of the Ad-Hoc Committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol 2007; 68: 392-417.
4. Tiercy JM, Nicoloso G, Passweg J, Schanz U, Seger R, Chalandon Y et al. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007; 40: 515-522.
5. Nowak J, Graczyk-Pol E, Mika-Witkowska R, Zajko M, Rogatko-Koros M, Sak-Budzisz J. Efficacy of bone marrow donor searches performed by Institute of Haematology and Transfusion Medicine in domestic and foreign registries in 1999-2006 for the patients with acute and chronic leukemia. Postepy Nauk Med 2007; 20: 298-303 (Eng. abstract).
6. Cohen BA, Mitra RD, Hughes JD, Church GM. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat Genet 2000; 26: 183-186.
7. Godder KT, Henslee-Downey PJ, Mehta J, Park B, Chiang K-Y, Abhyankar S et al. Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 2007; 39: 751-757.
8. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 40: 1055-1062.
9. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40: 63-70.
10. Özdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M et al. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007; 40: 125-136.
11. Cheuk DKL, Wang P, Lee TL, Chiang AKS, Ha SY, Lau YL et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 935-944.
12. Myers GD, Bollard CM, Wu M-F, Weiss H, Rooney CM, Heslop HE et al. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 677-686.
13. Viollier R, Socié G, Tichelli A, Bacigalupo A, Korthof E, Marsh J et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41: 45-50.
14. Vicente D, Lamparelli T, Gualandi F, Occhini D, Raiola AM, Ibatici A et al. Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant. Bone Marrow Transplant 2007; 40: 349-354.
15. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006; 24: 5695-5702.
16. Petersdorf EW, Gooley T, Malkki M, Horowitz M. Impact of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. In: Hansen JA (eds). Immunobiology of the human MHC (Proceedings of the 13th International Histocompatibility Workshop and Conference). IHWG Press: Seattle (in press).
17. Sedlacek P, Formankova R, Mejstrikova E, Keslova P, Hubacek P, Dobrovolna M et al. Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors. Pediatr Transplantation 2008; 12: 24-31.
18. Greinix HT, Fae I, Schneider B, Rosenmayr A, Mitterschiffthaler A, Pelzmann B et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35: 57-62.
19. Liao C, Wu JY, Xu ZP, Li Y, Yang X, Chen JS et al. Indiscernible benefit of high-resolution HLA typing in improving long-term clinical outcome of unrelated umbilical cord blood transplant. Bone Marrow Transplant 2007; 40: 201-208.
20. Heemskerk MBA, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FHJ, Doxiadis IIN et al. Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 193-200.
21. Bornhäuser M, Schwerdtfeger R, Martin H, Frank C, Theuser C, Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 2004; 103: 2860-2861.
22. Lowe EJ, Turner V, Handgretinger R, Horwitz EM, Benaim E, Hale GA et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. British Journal of Haematology 2003; 123: 323-326.
23. Ottinger HD, Beelen DW, Peceny R, Elmaagacli AH, Grosse-Wilde H. Change of paradigm in donor selection for hematopoietic stem cell transpiantation: For patients above 40 years with early stage leukaemia HLA-identical siblings are no longer first choice. Bone Marrow Transplant 2004; 33 (Suppl 1): S68 (abstr. O376).
24. Finke J, Schmoor C, Lang H, Potthoff K, Bertz H. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. J Clin Oncol 2003; 21: 506-513.
25. Morishima Y, Kawase T, Malkki M, Petersdorf EW. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens 2007; 69 (Suppl 1): 31-35.
26. Hurley CK, Fernandez-Vina M, Hildebrand WH, Noreen HJ, Trachtenberg E, Williams TM et al. A high degree of HLA disparity arises from limited allelic diversity: Analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol 2007; 68: 30-40.
27. Nowak J, Kalinka-Warzocha E, Juszczyñski P, Mika-Witkowska R, Zajko M, Graczyk-Pol E et al. Haplotype-specific pattern of association of human MHC with non-Hodgkin's lymphoma outcome. Tissue Antigens 2008; 71: 16-26.
28. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database:. www.allelefrequencies.net. Tissue Antigens 2003; 61 403-407.
29. Ferrara GB, Bacigalupo A, Lamparelli T, Lanino E, Delfino L, Morabito A et al. Bone marrow transplantation from unrelated donors: The impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001; 98: 3150-3155.
30. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235-2241.
31. Nowak J, Rogatko-Koros M, Zajko M, Mika-Witkowska R, Graczyk-Pol E, Sak-Budzisz J. Wpływ substytucji aminokwasu w pozycji 116 cza̧steczki MHC klasy I na wynik transplantacji komórek krwiotwórczych - krytyczna analiza. Acta Haematol Pol 2007; 38 (Suppl 2): 84-85 (abstract 048).
32. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521-1526.
33. Giebel S, Locatelli FW, Lamparelli T, Velardi A, Davies S, Framento G et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814-819.
34. Petersdorf EW, Gooley T, Horowitz M. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietifc cell transplantation from unrelated donors. Tissue Antigens 2007; 69 (Suppl 1): 25-30.